Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Mesothelioma Clinical Trials
A listing of Mesothelioma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Florida
Tampa : H. Lee Moffitt Cancer Center
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Illinois
Elgin : Sherman Health
SWOG S0905 Phase I/II Randomized Study of Pemetrexed Disodium and Cisplatin With Versus Without Cediranib Maleate in Patients With Malignant Pleural Mesothelioma
View More »
Chicago : University of Chicago
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Maryland
Bethesda : National Cacner Institue
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Bethesda : National Cancer Institute
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Minnesota
New Jersey
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
New York
Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
New York : New York University Cancer Center
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
New York : Memorial Sloan-Kettering Cancer Center
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
New York : Memorial Sloan-Kettering Cancer Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
View More »
Sleepy Hollow : Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Oklahoma
Tennessee
Texas
Houston : Md Anderson Cancer Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Belgium
Antwerpen : UZ Antwerpen
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Ghent : University Hospital Ghent
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Mechelen : AZ St. Maarten
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Canada
Toronto : University Health Network
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Italy
Alessandria : Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Casale Monferrato : Ospedale Santo Spirito
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Genova : Asl 3 genovese, Ospedale Villa Scassi
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Pavia : IRCCS Policlinico S. Matteo
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Rozzano : Istituto Clinico Humanitas
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
View More »
Siena : Medical Oncology and Immunotherapy Unit, University Hospital of Siena
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Treviso : Ospedale Ca' Foncello
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Netherlands
Amsterdam : Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Axitinib in Malignant Mesothelioma
Heerlen : AMC Heerlen
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
United Kingdom
Sheffield : Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
